Related Experiment Video
Updated: Jan 20, 2026

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic
Keiichiro Suzuki1,2,3, Mako Yamamoto4, Reyna Hernandez-Benitez4
1Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, 92037, USA. ksuzuki@chem.es.osaka-u.ac.jp.
Abstract:
In vivo genome editing represents a powerful strategy for both understanding basic biology and treating inherited diseases. However, it remains a challenge to develop universal and efficient in vivo genome-editing tools for tissues that comprise diverse cell types in either a dividing or non-dividing state. Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor. As a proof-of-concept, we focused on a mouse model of premature-aging caused by a dominant point mutation, which is difficult to repair using existing in vivo genome-editing tools. Systemic treatment using our new method ameliorated aging-associated phenotypes and extended animal lifespan, thus highlighting the potential of this methodology for a broad range of in vivo genome-editing applications.
Related Concept Videos
Homologous Recombination
Genome Size and the Evolution of New Genes
Genetics of Speciation
CRISPR/Cas9 Genome Editing
What is Genetic Engineering?
RNA Editing

